http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107988105-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-07 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 |
filingDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107988105-B |
titleOfInvention | Marine bacillus and application thereof |
abstract | The invention belongs to the technical field of biological medicines, and particularly relates to a marine bacillus and application thereof. The marine Bacillus is polysaccharide-producing marine bacterium Bacillus sp.BS11, and the application of the strain in preparing anticancer drugs, anti-tumor metastasis drugs, anticancer health care products or anti-cancer recurrence health care products; the marine bacillus is separated from the Haishan and can be used for preparing anticancer drugs or anticancer health products or preparing drugs for resisting tumor metastasis or health products for resisting tumor formation. The invention discloses application of bacillus exopolysaccharide in preparing anti-cancer and anti-tumor metastasis medicaments and health-care products, which can inhibit the expression of beta III-tubulin in A549 cells, inhibit the formation of byssus on the surfaces of cancer cells, inhibit the adherence and attachment of the A549 cells, inhibit the metastasis of the A549 cells, and finally cause anoikis of the cells, thereby having certain prevention and treatment effects on malignant tumors. |
priorityDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.